Here's the live share price of Procter & Gamble Health along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Procter & Gamble Health has declined 4.43% CAGR. Over the past year, the corresponding return has been 4.39%.
Procter & Gamble Health’s current P/E of 29.34x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Procter & Gamble Health | -4.98 | -4.47 | -11.63 | -6.75 | 1.99 | 10.02 | -4.43 |
| Sun Pharmaceutical Industries | -2.96 | -3.75 | 4.58 | 2.84 | -2.20 | 18.84 | 23.50 |
| Divi's Laboratories | -3.14 | 1.37 | -1.91 | -5.15 | 7.27 | 24.28 | 11.57 |
| Torrent Pharmaceuticals | -3.70 | 4.21 | 11.96 | 15.64 | 21.07 | 36.43 | 23.28 |
| Cipla | -1.31 | -3.92 | -6.76 | -2.46 | 0.01 | 10.67 | 11.47 |
| Dr. Reddy's Laboratories | -4.20 | -7.03 | -3.79 | -4.84 | -10.99 | 11.24 | 2.38 |
| Lupin | -1.94 | 3.85 | 12.03 | 12.78 | 0.72 | 42.16 | 15.25 |
| Mankind Pharma | -4.44 | 3.08 | -9.32 | -18.18 | -17.31 | 15.76 | 9.18 |
| Zydus Lifesciences | -3.01 | -2.39 | -8.16 | -7.15 | -10.15 | 26.78 | 13.06 |
| Alkem Laboratories | 1.28 | 4.42 | 6.72 | 21.15 | 11.23 | 24.64 | 13.69 |
| Aurobindo Pharma | -6.17 | -2.23 | 3.17 | 1.78 | -1.34 | 38.62 | 4.12 |
| Abbott India | -1.21 | 0.91 | -6.49 | -18.14 | -0.37 | 8.14 | 13.40 |
| Laurus Labs | -6.33 | 5.27 | 20.61 | 28.27 | 86.04 | 43.60 | 24.88 |
| Biocon | -2.84 | -3.67 | 6.95 | -0.79 | -2.97 | 14.27 | -4.07 |
| Glenmark Pharmaceuticals | -5.28 | 0.82 | 5.69 | -9.77 | 32.12 | 68.24 | 31.26 |
| GlaxoSmithKline Pharmaceuticals | -3.11 | -7.52 | -13.82 | -25.28 | 14.64 | 22.11 | 9.26 |
| Ipca Laboratories | -0.71 | 4.27 | 15.23 | 3.14 | -5.37 | 19.98 | 7.48 |
| Anthem Biosciences | -4.74 | -10.62 | -19.14 | -14.48 | -14.48 | -5.08 | -3.08 |
| Ajanta Pharma | -4.40 | 3.36 | 14.01 | 2.98 | -3.10 | 32.30 | 18.16 |
| Emcure Pharmaceuticals | 1.38 | 10.88 | 15.60 | 14.27 | 14.59 | 4.45 | 2.65 |
Over the last one year, Procter & Gamble Health has gained 1.99% compared to peers like Sun Pharmaceutical Industries (-2.20%), Divi's Laboratories (7.27%), Torrent Pharmaceuticals (21.07%). From a 5 year perspective, Procter & Gamble Health has underperformed peers relative to Sun Pharmaceutical Industries (23.50%) and Divi's Laboratories (11.57%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 5,635.91 | 5,533.31 |
| 10 | 5,678.45 | 5,600.1 |
| 20 | 5,669.35 | 5,649.48 |
| 50 | 5,771.5 | 5,764.98 |
| 100 | 6,025.56 | 5,850.15 |
| 200 | 5,818.15 | 5,792.37 |
In the latest quarter, Procter & Gamble Health saw a drop in promoter holding to 51.82%, while DII stake decreased to 13.84%, FII holding fell to 6.97%, and public shareholding moved up to 27.37% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 6,92,659 | 0.58 | 396.37 | |
| 3,60,975 | 2.44 | 206.57 | |
| 2,29,559 | 4.57 | 131.37 | |
| 1,59,288 | 2.87 | 91.15 | |
| 71,471 | 0.63 | 40.9 | |
| 69,716 | 1.1 | 39.9 | |
| 67,014 | 3.41 | 38.35 | |
| 22,442 | 0.39 | 12.84 | |
| 19,000 | 1.27 | 10.87 | |
| 12,000 | 0.39 | 6.87 |
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Dec 26, 2025, 5:32 AM IST | P&G Health - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On February 6, 2026. |
| Nov 18, 2025, 9:44 PM IST | P&G Health - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot |
| Nov 17, 2025, 11:24 PM IST | P&G Health - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot |
| Nov 17, 2025, 11:19 PM IST | P&G Health - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report |
| Nov 05, 2025, 8:17 PM IST | P&G Health - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
Procter & Gamble Health Ltd. is a Public Limited Listed company incorporated on 26/04/1967 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L99999MH1967PLC013726 and registration number is 013726. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 934.17 Cr. and Equity Capital is Rs. 16.60 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Procter & Gamble Health is ₹5,422.00 as on Jan 13, 2026.
The Procter & Gamble Health is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Procter & Gamble Health is ₹9,000.18 Cr as on Jan 13, 2026.
Today’s highest and lowest price of Procter & Gamble Health are ₹5,496.70 and ₹5,377.00.
The 52-week high/low is the highest and lowest price at which Procter & Gamble Health stock has traded in the past 52-week or nearly a year. The 52-week high of Procter & Gamble Health is ₹6,700.00 and 52-week low of Procter & Gamble Health is ₹4,916.00 as on Jan 13, 2026.
The Procter & Gamble Health has shown returns of -0.56% over the past day, -4.47% for the past month, -11.15% over 3 months, 4.39% over 1 year, 10.02% across 3 years, and -4.43% over 5 years.
P/E ratio of and PB ratio of Procter & Gamble Health are 29.34 and 14.52 on Jan 13, 2026. While the company gives a dividend yield of 2.31 per annum.